Ann Zahle Andersen

Ann Zahle Andersen is Chairperson of Life Science Fyn, where she works to strengthen the regional life science ecosystem by connecting companies, academia, and investors to drive innovation and growth. She has a passion for biotech startups and is Co-founder of GlyProVac, a spinout from University of Southern Denmark, developing a novel vaccine to prevent E. coli urinary tract infections and combat antimicrobial resistance.